Antiviral drug discovery: preparing for the next pandemic
Catherine S. AdamsonBiomedical Sciences Research ComplexKelly ChibaleDrug Discovery and Development Centre (H3D) and South African Medical Research Council Drug Discovery and Development Research UnitRebecca J. M. GossSt AndrewsMarcel JasparsMarine Biodiscovery CentreDavid NewmanNatural Products Branch, NIH/NCIRosemary A. DorringtonDept. of Biochemistry and Microbiology
2021en
Ochiq kirishGibrid
Litsenziya: cc-by-nc
ABI
Annotatsiya
Clinically approved antiviral drugs are currently available for only 10 of the more than 220 viruses known to infect humans. The SARS-CoV-2 outbreak has exposed the critical need for compounds that can be rapidly mobilised for the treatment of re-emerging or emerging viral diseases, while vaccine development is underway. We review the current status of antiviral therapies focusing on RNA viruses, highlighting strategies for antiviral drug discovery and discuss the challenges, solutions and options to accelerate drug discovery efforts.
Hali tarjima qilinmagan
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba